Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10162261 | Journal of Pharmaceutical Sciences | 2014 | 7 Pages |
Abstract
The performance of pressurized meteredâdose inhalers (pMDIs) under a variety of temperature conditions was investigated. The effects of both inhaler temperature and ambient temperature were considered. The inhaler temperature ranged from â13.0°C to 41.7°C and the ambient temperature ranged from â12.0°C to 41.7°C. The in vitro lung dose was measured for four widely available pMDIs: AiromirTM, QVARTM, Symbicort®, and Ventolin®. The in vitro lung dose through an Alberta Idealized Throat was measured by gravimetric assay, which was verified by UV spectroscopic assay. A decrease in the in vitro lung dose was observed for all evaluated pMDIs when ambient temperature and device temperature were simultaneously reduced, decreasing on average by 70% at the coldest temperatures, whereas increasing on average by 25% at the elevated temperature condition. In vitro lung dose is strongly dependent on both inhaler temperature and ambient temperature with the tested pMDIs.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Chelsea M.D. Morin, James W. Ivey, Jordan T.F. Titosky, Jonathan D. Suderman, Jason S. Olfert, Reinhard Vehring, Warren H. Finlay,